Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation sequencing is being explored as a complementary screening tool. A review published in Pediatric Investigation examines how next-generation sequencing could expand NBS from single-disease assays to genome-enabled, multi-disease screening approaches.

A new review reveals that Polygonum multiflorum (a traditional Chinese herbal medicine) can effectively combat androgenetic alopecia through multiple mechanisms: inhibiting the production of dihydrotestosterone, activating hair follicle regeneration pathways (Wnt/β-catenin, Shh), and improving scalp blood flow. Unlike existing drugs such as finasteride or minoxidil, it adopts a comprehensive multi-target approach, with fewer side effects and higher patient acceptance, supporting its development as a natural alternative for hair loss treatment.